Skip to main content
. 2022 Nov 24;22:409. doi: 10.1186/s12893-022-01850-2

Table 2.

Comparison of clinicopathological features and postoperative outcomes between two Duodenojejunostomy styles

Duodenojejunostomy Styles P value
S-style E-style
Gender 0.728
 Male 10 (47.6%) 5 (38.5%)
 Female 11 (52.4%) 8 (61.5%)
Age (mean ± SD, year) 60.10 ± 11.03 50.15 ± 13.24 0.024
Primary or Recurrence 0.126
 Primary 9 (42.9%) 9 (69.2%)
 Recurrence 12 (57.1%) 4 (30.8%)
Multiple Lesions 0.301
 Yes 8 (38.1%) 3 (23.1%)
 No 13 (61.9%) 10 (76.9%)
Tumor Size (mean ± SD, cm) 20.4 ± 11.8 16.6 ± 14.1 0.397
Histology 0.152
 LPS 12 (57.1%) 3 (23.1%)
 GIST 7 (33.3%) 7 (53.8%)
 LMS 2 (9.5%) 2 (15.4%)
 DT 0 (0.0%) 1 (7.7%)
Multivisceral Resection 0.008
 Yes 18 (85.7%) 5 (38.5%)
 No 3 (14.3%) 8 (61.5%)
Combined Pancreatic Resection* 0.229
 Yes 7 (33.3%) 2 (15.4%)
 No 14 (66.7%) 11 (84.6%)
Operation Time (mean ± SD, min) 358 ± 98 322 ± 154 0.418
Intraoperative Blood Loss (mean ± SD, ml) 1552 ± 1292 877 ± 1364 0.165
Complication 0.292
 Yes 12 (57.1%) 10 (76.9%)
 No 9 (42.9%) 3 (23.1%)
Delayed Gastric Emptying 0.011
 Yes 11 (52.4%) 1 (7.7%)
 No 10 (47.6%) 12 (92.3%)
Incision Infection 0.465
 Yes 8 (38.1%) 3 (23.1%)
 No 13 (61.9%) 10 (76.9%)
Intraperitoneal Infection 0.030
 Yes 12 (57.1%) 2 (15.4%)
 No 9 (42.9%) 11 (84.6%)
Duodenojejunal anastomotic Fistula 0.370
 Yes 5 (23.8%) 1 (7.7%)
 No 16 (76.2%) 12 (92.3%)
Pancreatic Fistula 0.210
 Yes 6 (28.6%) 1 (7.7%)
 No 15 (71.4%) 12 (92.3%)
Postoperative Massive Hemorrhage 1.000
 Yes 2 (10.5%) 1 (7.7%)
 No 19 (89.5%) 12 (92.3%)
Unplanned re-operation 1.000
 Yes 2 (10.5%) 1 (7.7%)
 No 19 (89.5%) 12 (92.3%)
Time to Feed (mean ± SD, day) 22.0 ± 16.0 13.8 ± 25.4 0.255
Postoperative Hospital Stay (mean ± SD, day) 30.5 ± 14.8 21.4 ± 26.6 0.208

LPS: liposarcoma; LMS: leiomyosarcoma; GIST: gastrointestinal stromal tumor; DT: desmoid tumor; SD: stand deviation

*Refers to the removal of the uncinate or the body and tail of the pancreas